Shiota G - Search Results

1

Hepatocellular carcinoma development in diabetic patients: a nationwide survey in Japan.

Tateishi R, Matsumura T, Okanoue T, Shima T, Uchino K, Fujiwara N, Senokuchi T, Kon K, Sasako T, Taniai M, Kawaguchi T, Inoue H, Watada H, Kubota N, Shimano H, Kaneko S, Hashimoto E, Watanabe S, Shiota G, Ueki K, Kashiwabara K, Matsuyama Y, Tanaka H, Kasuga M, Araki E, Koike K; LUCID study investigators. Tateishi R, et al. Among authors: shiota g. J Gastroenterol. 2021 Mar;56(3):261-273. doi: 10.1007/s00535-020-01754-z. Epub 2021 Jan 11. J Gastroenterol. 2021. PMID: 33427937 Free PMC article.

2

Clinical significance of serum guanase activity in various liver diseases.

Shiota G, Fukada J, Ito T, Tsukizawa M, Yamada M, Sato M. Shiota G, et al. Jpn J Med. 1989 Jan-Feb;28(1):22-4. doi: 10.2169/internalmedicine1962.28.22. Jpn J Med. 1989. PMID: 2542677 Free article.

3

Serum hepatocyte growth factor levels in liver diseases: clinical implications.

Shiota G, Okano J, Kawasaki H, Kawamoto T, Nakamura T. Shiota G, et al. Hepatology. 1995 Jan;21(1):106-12. Hepatology. 1995. PMID: 7806142

4

Serum hepatocyte growth factor in acute hepatic failure in comparison with acute hepatitis.

Shiota G, Okano J, Umeki K, Kawasaki H, Kawamoto T, Nakamura T. Shiota G, et al. Res Commun Mol Pathol Pharmacol. 1994 Aug;85(2):157-62. Res Commun Mol Pathol Pharmacol. 1994. PMID: 7994560

5

Hepatocyte growth factor and acute phase proteins in patients with chronic liver diseases.

Shiota G, Umeki K, Okano J, Kawasaki H. Shiota G, et al. J Med. 1995;26(5-6):295-308. J Med. 1995. PMID: 8721905

6

Rupture of metastatic nodule on the peritoneal surface secondary to hepatocellular carcinoma.

Okano J, Shiota G, Horie Y, Mitsuda A, Suou T, Kawasaki H, Oofuji S. Okano J, et al. Among authors: shiota g. Intern Med. 1996 Oct;35(10):783-4. doi: 10.2169/internalmedicine.35.783. Intern Med. 1996. PMID: 8933186 Free article.

7

Protective action of hepatocyte growth factor for acute liver injury caused by D-galactosamine in transgenic mice.

Okano J, Shiota G, Kawasaki H. Okano J, et al. Among authors: shiota g. Hepatology. 1997 Nov;26(5):1241-9. doi: 10.1053/jhep.1997.v26.pm0009362368. Hepatology. 1997. PMID: 9362368

8

Prognostic significance of serum anti-p53 antibody in patients with hepatocellular carcinoma.

Shiota G, Kishimoto Y, Suyama A, Okubo M, Katayama S, Harada K, Ishida M, Hori K, Suou T, Kawasaki H. Shiota G, et al. J Hepatol. 1997 Oct;27(4):661-8. doi: 10.1016/s0168-8278(97)80083-9. J Hepatol. 1997. PMID: 9365042 Clinical Trial.

9

Interferon-alpha therapy alters glucose metabolism in patients with chronic hepatitis B.

Tanaka H, Shiota G, Kawasaki H. Tanaka H, et al. Among authors: shiota g. J Med. 1997;28(5-6):325-34. J Med. 1997. PMID: 9604791

10

Changes in glucose tolerance after interferon-alpha therapy in patients with chronic hepatitis C.

Tanaka H, Shiota G, Kawasaki H. Tanaka H, et al. Among authors: shiota g. J Med. 1997;28(5-6):335-46. J Med. 1997. PMID: 9604792

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

203 results

Search Page

Filters